comparemela.com

Page 10 - Harald Rau News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ascendis Pharma A/S (NASDAQ:ASND) Cut to Neutral at Credit Suisse Group

Ascendis Pharma A/S (NASDAQ:ASND – Get Rating) was downgraded by analysts at Credit Suisse Group from an “outperform” rating to a “neutral” rating in a research note issued on Monday, MarketBeat Ratings reports. A number of other brokerages have also weighed in on ASND. Wells Fargo & Company upped their target price on shares of […]

New zealand generalNew zealandDirk vetterJan moller mikkelsenAscendis pharmaHarald rauWells fargo companyT rowe price investment management incPricet rowe associates incAvoro capital advisorsAscendis pharmaas company profileMorgan stanleyWellington management groupGoldman sachs group incCredit suisse groupGet rating

Ascendis Pharma (ASND) Receives a Buy from Bank of America Securities

Bank of America Securities analyst Tazeen Ahmad reiterated a Buy rating on Ascendis Pharma (ASND – Research Report) today and set a price .

United statesJan moller mikkelsenTazeen ahmadAscendis pharmaHarald rauBerenberg bankAmerica securitiesResearch reportSarepta therapeuticsStrong buy

Ascendis Pharma (ASND) Receives a Buy from Morgan Stanley

Morgan Stanley analyst Vikram Purohit maintained a Buy rating on Ascendis Pharma (ASND – Research Report) yesterday and set a price target.

Vikram purohitAscendis pharmaHarald rauJan moller mikkelsenMorgan stanleyResearch reportAxsome therapeuticsStrong buy

Wedbush Keeps Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Andreas Argyrides from Wedbush reiterated a Buy rating on Ascendis Pharma (ASND – Research Report), with a pri.

Ascendis pharmaHarald rauVerona pharmaAndreas argyridesJan moller mikkelsenMorgan stanleyResearch reportStrong buy

Morgan Stanley Reaffirms Their Buy Rating on Ascendis Pharma (ASND)

In a report released today, Vikram Purohit from Morgan Stanley maintained a Buy rating on Ascendis Pharma (ASND – Research Report), with a.

Ascendis pharmaHarald rauVikram purohitJan moller mikkelsenMorgan stanleyBerenberg bankResearch reportAxsome therapeuticsStrong buy

vimarsana © 2020. All Rights Reserved.